Biofrontera (BFRI)

• Market cap: $9.32M
• 1 day: 1.52%
• 5 days: 2.63%
• 1 month: -24.48%
• 3 months: -5.99%
• 6 months: 30.44%
• Year to date: -26.56%
• 1 year: -11.06%
• 5 years: -99.09%
• 10 years: -99.09%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.

Employees: 93